ASRT vs BA · rev $125.0M vs P/E 89, rev $89.46B
Assertio Therapeutics Inc (ASRT) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
ASRT currently screens at market cap $151.5M. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the ASRT and BA stock pages for the full models.
Not investment advice.